Fampridine's effect on memory in mild to moderate depression
Part of Mental health clinical trials.
This study tests whether the drug fampridine can improve working memory (like short-term memory and focus) in people with mild to moderate depression. The trial is run by the University of Basel and involves multiple visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You have mild to moderate depression (not severe).
- You are not currently taking any antidepressant or antipsychotic medication.
- You have no history of seizures or a condition that lowers your seizure threshold.
- You are fluent in German and willing to follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a medication called memantine affects memory and mood in people with major depression who are not currently taking antidepressants. It involves MRI scans and may help find new ways to treat depression.
This study tests whether a targeted medication can improve mood and brain function in adults with major depression. If you qualify, you'll receive a study drug and have fMRI brain scans to see how your brain responds.
This study tests how well the antidepressant trazodone works in older adults with major depression and mild cognitive impairment (early memory or thinking problems). It looks at real-world results in people starting this treatment.
This trial tests a new medication called RP902 to see if it can safely help people with mild cognitive impairment—the early stage of memory and thinking problems that may lead to dementia. Researchers will measure how well it works and monitor for side effects.
This trial studies a non-medication (non-drug) program to improve memory and daily thinking in people with mild cognitive impairment or mild Alzheimer’s disease. It may help by supporting brain function and monitoring symptoms over time.
This early-phase study tests whether psilocybin (a psychedelic substance) can help with depression in people who have mild memory problems or early Alzheimer’s. The trial also closely monitors safety, thinking changes, mood, and blood pressure before and after dosing.
Hear when a new Working Memory trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.